Management and Board

Dr. Margareta Krook, Chairman

(elected year 2002)

Dr. Margareta Krook was born in 1967. She became a Ph. D. in Applied Biochemistry in 1998 (Lund University) and M. Sc. in Chemical Engineering 1993 (Lund University). Has several years experience in management. Dr Margareta Krook has worked with technical and business development and management in Chemel AB since year 2000. She was CEO in Chemel AB/Biotech-IgG AB from 2003-2010 and in the first quarter of 2011. She is the CEO of Implementa Hebe AB. Margareta Krook is a board member of Biotech-IgG A/S, Biotech-IgG (UK), Implementa Hebe AB and ScienceHouse Lund AB. She has 10 scientific publications and two approved patents. Margareta Krook is independet from the major shareholders of Biotech-IgG AB. Holds 44 250 shares in Biotech-IgG AB.

Ulric Aspegrén, Member of the Board

(elected 03/05/2011)

Born 1964. Batchelor of Science in elctro and computer science (University of Colorado, Boulder, USA). Has worked for more than 20 years at Tetrapak in leading positions in marketing and sales. From this he has a received a solid knowledge aobut international marketing operations. Board member of Amiralen AB and Tomtebogården AB. Ulric Aspegrén is independent from the major shareholders of Biotech-IgG AB. Holds 871 000 shares in Biotech-IgG AB.

Edvard Skodic, Member of the Board

(elected 26/04/2010)

Born in 1974. Slovenian citizen. University exam in telecommunication (University of Ljubjana, Slovenia). Works as specialist in information technology in a leading company in Slovenia. Has worked in several positions with information technology in Delta Malta Ltd (Malta) and Telemach doo (Slovenia). Has no other board assignments. Edvard Skodic is independent from the major shareholders of Chemel AB. Holds 0 shares in Biotech-IgG AB.

Docent/Ass Prof Dario Kriz, CEO

(appointed 2012)

Born 1965. He became Ph.D. in Biochemistry in 1994, visiting professor at the University of Regensburg (Germany) during 1997-1998, and associate professor in 2004. He is the inventor of several products and methods in medical technology and biotechnology. He has 25 scientific publications and 13 approved patents. He is president of European Institute of Science AB and member of the board of ScienceHouse Lund AB. He holds together with Kirstin Kriz 268 450 shares in Biotech-IgG AB and 2 343 800 shares through European Institute of Science AB.

Dr Kirstin Kriz, CEO Biotech-IgG A/S

(appointed 2012)

Born in 1975. Batchelor of Science 1997 (University of California, San Diego, USA) PhD 2003 (Lund University). She has worked as head of quality and R&D Manager in the stock company LifeAssays AB and handled the communication with international suppliers and distributors within the LifeScience area. She is main owner and board member of European Institute of Science AB since 2004. Kirstin Kriz has published 10 scientific articles and patent applications. She has been rewarded with several American prestigeous titles such as UCSD Regents Scholarship (1995) and an honorary membership in Phi Beta Kappa (1997). She was the president of Biotech-IgG AB during 2011-2012. She holds together with Dario Kriz 268 450 shares in Biotech-IgG AB and 2 343 800 shares through European Institute of Science AB.

Helene Vester, CFO Biotech-IgG AB

(appointed March 2011)

Born in 1967, Helene Vester is the CFO of Biotech-IgG AB. Helene has worked as CFO/Economy director earlier and she has a university degree at Lund University with expertise in accounting/auditing. Helene has a vast experience within the economy area, among other things she has experience in accounting and financial reporting in listed companies since she has worked as head responsible person in these areas in small, medium and large companies. Helene Vester owns 0 shares in Biotech-IgG AB.